Vijay Vaswani
Co-Founder/CEO
Omniscope
Omniscope provides immune system analysis platforms tailored for pharmaceutical development, sports performance optimization, and longevity research. The company utilizes advanced tracking and profiling methods to generate actionable insights from immune cell activity data. This intelligence supports the engineering of novel therapies and the enhancement of healthspan across various applications.
- Artificial Intelligence
- Data & Analytics
- Biotechnology
- Healthcare Technology
Updated 7 months ago
Funding
Raised to date
$5.3MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Problem
Current methods for analyzing the adaptive immune system to understand disease mechanisms and develop targeted therapies are limited by the scale and resolution of available immune cell sequencing data. Translating research insights into clinical diagnostics and therapeutics is often slow and inefficient.
Solution
Omniscope is developing a large-scale immune databank that leverages high-resolution immune cell sequencing and artificial intelligence to decode the adaptive immune system. The platform aims to enhance the understanding of immune responses in conditions such as cancer, infectious diseases, and autoimmune diseases. By reading, analyzing, and writing the adaptive immune system, Omniscope facilitates the characterization of prognostic and therapeutic cells, with the goal of accelerating the translation of research into impactful healthcare solutions. The Omniscope Immune Portal provides direct access to public datasets, enabling users to browse and explore T cell receptor (TCR) repertoires related to COVID-19 longitudinal studies and immunotherapy.
Target Audience
The primary audience includes researchers and innovators in oncology, infectious diseases, and autoimmune diseases, as well as those focused on developing diagnostics and therapeutics.
Features
- High-resolution immune cell sequencing for in-depth analysis of the adaptive immune system.
- AI-powered platform to decode and analyze immune responses for diagnostics and therapeutic design.
- Omniscope Immune Portal for accessing and exploring T cell repertoire (TCR) datasets.
- Capabilities to characterize prognostic and therapeutic cells.
- Services for immunosequencing at scale.
- Tools for immune fitness tracking and inflammation level monitoring.
- Features to discover immune age and disease protection.